260 related articles for article (PubMed ID: 26972337)
1. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
[TBL] [Abstract][Full Text] [Related]
3. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
[TBL] [Abstract][Full Text] [Related]
4. Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis.
Larish A; Mert I; McGree M; Weaver A; Sheedy S; Cilby W
Int J Gynecol Cancer; 2020 Apr; 30(4):504-508. PubMed ID: 31953350
[TBL] [Abstract][Full Text] [Related]
5. Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.
LaFargue CJ; Bristow RE
Gynecol Oncol; 2015 Sep; 138(3):762-3. PubMed ID: 26049122
[No Abstract] [Full Text] [Related]
6. FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
Hynninen J; Auranen A; Carpén O; Dean K; Seppänen M; Kemppainen J; Lavonius M; Lisinen I; Virtanen J; Grénman S
Gynecol Oncol; 2012 Jul; 126(1):64-8. PubMed ID: 22542580
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative Ultrasound-Guided Excision of Cardiophrenic Lymph Nodes in an Advanced Ovarian Cancer Patient.
Moro F; Uccella S; Testa AC; Scambia G; Fagotti A
Int J Gynecol Cancer; 2018 Nov; 28(9):1672-1675. PubMed ID: 30371564
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
9. Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer.
Luger AK; Steinkohl F; Aigner F; Jaschke W; Marth C; Zeimet AG; Reimer D
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1092-1099. PubMed ID: 32112653
[TBL] [Abstract][Full Text] [Related]
10. Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging.
Salehi S; Mohammar R; Suzuki C; Joneborg U; Hjerpe E; Torbrand C; Falconer H
Acta Oncol; 2018 Jun; 57(6):820-824. PubMed ID: 29182048
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.
Garbi A; Zanagnolo V; Colombo N; Aletti G; Achilarre MT; Bocciolone L; Landoni F; Rizzo S; Biffi R; Maggioni A
Int J Gynecol Cancer; 2017 Jul; 27(6):1268-1273. PubMed ID: 28498236
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.
Kim TH; Lim MC; Kim SI; Seo SS; Kim SH; Park SY
Ann Surg Oncol; 2016 Apr; 23(4):1302-8. PubMed ID: 26714941
[TBL] [Abstract][Full Text] [Related]
13. Metastatic cardiophrenic lymph node resection following full-thickness resection of right diaphragm for advanced ovarian carcinoma.
Nishikimi K; Tate S; Matsuoka A; Shozu M
Gynecol Oncol; 2018 Sep; 150(3):581-583. PubMed ID: 30032929
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A
Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398
[TBL] [Abstract][Full Text] [Related]
15. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E
Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581
[TBL] [Abstract][Full Text] [Related]
16. Radiologically enlarged cardiophrenic lymph nodes and CA-125 in relation to diaphragmatic carcinomatosis, surgical outcome, and overall survival in advanced ovarian cancer.
Plana A; Talo R; Wallengren NO; Pudaric S; Sartor H; Asp M
Acta Oncol; 2023 May; 62(5):451-457. PubMed ID: 37129994
[TBL] [Abstract][Full Text] [Related]
17. What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival.
Addley S; Asher V; Kirke R; Bali A; Abdul S; Phillips A
Eur J Surg Oncol; 2022 Dec; 48(12):2531-2538. PubMed ID: 35718677
[TBL] [Abstract][Full Text] [Related]
18. The role of lymphadenectomy in node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Millan I; Iglesias E
Int J Gynecol Cancer; 2012 Jul; 22(6):987-92. PubMed ID: 22706223
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
20. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study.
Zhou J; Zhang WW; Zhang QH; He ZY; Sun JY; Chen QH; Wu SG
Int J Surg; 2018 Apr; 52():11-15. PubMed ID: 29432972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]